Establishing an open and robotic pancreatic surgery program in a level 1 trauma center community teaching hospital and comparing its outcomes to high-volume academic center outcomes: a retrospective review

Table 2 Comparisons of the total study cohort with patients of HVAS

	CCS	HVAS	P-value	Mid-P	RR
PD %	38/64 (59.4%)	1347/2017 (66.8%)	0.227
DP %	16/64 (25.0%)	643/2017 (31.9%)	0.276
ASA ≥ 3%	64/64 (100%)	441/1571 (28.1%)	< 0.001		3.6
90-day mortality %	0/64 (0%)	32/1403 (2.3%)	0.397
POPF %	2/63 (3.2%)	489/2658 (18.4%)	< 0.001		5.8
Reoperation %	2/64 (3.1%)	130/1498 (8.7%)		0.051	2.8
SSI %	2/64 (3.1%)	302/1431 (21.1%)	< 0.001		6.8
DGE %	10/64 (15.6%)	253/2385 (10.6%)	0.216
CD III–IV %	7/64 (10.9%)	118/541 (21.8%)	0.049	0.018	2.0
Readmission %	13/64 (20.3%)	87/474 (18.4%)	0.732

HVAS high-volume academic center studies, CCS current community study, RR risk ratio; PD pancreaticoduodenectomy, DP distal pancreatectomy, ASA American Society of Anesthesiologists physical status, POPF grade B or C postoperative pancreatic fistula, SSI surgical site infection, DGE delayed gastric emptying, CD III–IV Clavien–Dindo grades III–IV complication

ISSN: 1471-2482